Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold?

ABSTRACT:

Background

The decreasing cost of next-generation sequencing technologies (NGS) has resulted in their increased use in research, and in the clinic. However, France and Quebec have not yet implemented nation-wide personalized medicine programs using NGS. To produce policies on the large-scale implementation of NGS, decision makers could benefit from a detailed understanding of how these technologies are currently used, their limitations, and the benefits they could bring to patients.

Objectives

We aimed at answering two research questions: How are patients' NGS data currently managed in healthcare institutions in Quebec and in France? What issues do technology users identify which should be solved in order to implement clinical genomics at the national level?

Method

Th

SUBMITTER: Bertier G 

PROVIDER: S-EPMC6068066 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature